Memory, not thinking speed, lagged in early relapsing MS

Credibility

Interest

Share:2 min read

Key Takeaway

People with early relapsing MS had more trouble with memory, but not thinking speed, than people without MS.

What They Found

In one group, people with early relapsing MS scored lower on memory tests than people without MS. Their thinking speed was similar, and it stayed stable over the next six years despite a small memory decline. In a separate group, poor memory scores were more common than expected, while thinking speed and attention scores were not. Patients reported the most trouble finding words, followed by holding information in mind and remembering events. People with secondary progressive MS were an exception: they also had difficulties with attention and thinking speed.

Who Should Care and Why

The researchers studied adults with MS that began with relapses, including people with early relapsing MS. They also studied people with secondary progressive MS and people without MS for comparison. The findings are especially relevant to people who notice memory trouble even when they can still think quickly. They describe how thinking and memory differed among the groups studied. They do not show that current MS treatments caused those differences.

Important Considerations

You should know this was an observational study, not a treatment test. It included 170 people with early relapsing MS, 45 people without MS, and a separate group of 1,004 patients. You cannot tell from these comparisons why memory and thinking speed differed.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Specific Symptoms

Article Topics:

cognitionmemorymultiple sclerosispatient-reported outcome measuresprocessing speedworking memory

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Brain : a journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News